MedTrace Logo

Randomised Controlled Trial of Efficacy of Resistant Maltodextrins on Reducing Colonic Transit Time

NCT01802112 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-04-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of resistant maltodextrins, compared to placebo, in reducing the colonic transit time in healthy subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Resistant maltodextrins

15 grams of Resistant maltodextrins per day dissolved in water during 21 days

OTHER

placebo

15gr placebo

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    collaborator OTHER

  • Hospital Virgen de la Vega

    collaborator OTHER

  • San Antonio Technologies - San Antonio Catholic University of Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-03-31
Completion
2013-06-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01802112 on ClinicalTrials.gov